
Synerlab
A wide skillset from product development to contract-manufacturing and packaging.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
investor | €0.0 | round | |
* | N/A | Buyout | |
Total Funding | 000k |
Related Content
Synerlab is a European Contract Development and Manufacturing Organization (CDMO) that specializes in pharmaceutical development, manufacturing, and packaging. The company serves a diverse range of clients, including both generic and non-generic pharmaceutical firms across Europe. Synerlab operates in the pharmaceutical industry, focusing on small to mid-size series production. The business model revolves around long-term partnerships with pharmaceutical companies, leveraging their expertise in industrial transfer, drug formulation, and clinical batch production from phase 1 to phase 3. Synerlab generates revenue through its comprehensive suite of services, which include research and development, galenics and analytics, and a wide range of manufacturing processes. The company continuously invests in enhancing its capacity and expanding its service offerings to meet the evolving needs of its clients.
Keywords: CDMO, pharmaceutical development, manufacturing, packaging, drug formulation, clinical batches, industrial transfer, Europe, long-term partnerships, flexibility.
Tech stack
Investments by Synerlab
Edit